Table 3. Comparison of Comorbidities in Pediatric Lymphoma Patients in the United States with In-Hospital Mortality Being the Outcome, 2012 (n=2,908) .

Chi-Square: Categorical Variables

Independent Samples T-Test: Continuous Variables

N/A: Not Applicable

n: Population Number

	Mortality % (n=34)	No Mortality % (n=2,801)	P-Value
Obesity	0.0% (0)	2.6% (73)	N/A
Deficiency Anemias	14% (5)	9.1% (254)	0.180
Rheumatoid Arthritis/Collagen Vascular Disease	0.0% (0)	0.4% (11)	N/A
Chronic Blood Loss Anemia	0.0% (0)	0.5% (14)	N/A
Congestive Heart Failure	8.8% (3)	0.4% (12)	0.001
Chronic Pulmonary Disease	2.9% (1)	8.2% (229)	0.236
Coagulopathy	41% (14)	11% (314)	< 0.001
Depression	5.9% (2)	4.8% (135)	0.481
Diabetes, Uncomplicated	2.9% (1)	0.9% (26)	0.273
Diabetes, with chronic complications	0.0% (0)	0.1 % (2)	N/A
Drug Abuse	2.9% (1)	1.7% (48)	0.441
Hypertension (combined uncomplicated and complicated)	12% (4)	6.2% (174)	0.151
Hypothyroidism	0.0% (0)	2.1% (59)	N/A
Liver Disease	5.9% (2)	1.4% (39)	.082
Fluid and Electrolyte Disorders	76% (26)	19% (540)	< 0.001
Metastatic Cancer	5.9% (2)	0.7% (19)	0.024
Neurological Disorder	12% (4)	3.4% (95)	0.027
Paralysis	5.9% (2)	1.2% (35)	0.069
Peripheral Vascular Disorders	2.9% (1)	0.2% (5)	0.068
Psychosis	0.0% (0)	1.3% (37)	N/A
Pulmonary Circulation Disorders	2.9% (1)	0.7% (19)	0.210
Renal Failure	12% (4)	2.1% (59)	0.006
Solid Tumor without Metastasis	0.0% (0)	0.6% (18)	N/A
Valvular Disease	2.9% (1)	0.4% (11)	0.132
Weight Loss	8.8% (3)	0.4% (11)	0.160